Advertisement
Screener

SCYNEXIS, Inc. (SCYX) Proceeds from Issuance of Secured Debt

1.5 / 5 stars · 27/92 Roast Me

SCYNEXIS, Inc. Proceeds from Issuance of Secured Debt

SCYNEXIS, Inc. (SCYX) reported Proceeds from Issuance of Secured Debt of $0 for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-07.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfSecuredDebt · last filed 2018-03-13

  • SCYNEXIS, Inc. proceeds from issuance of secured debt for the quarter ending 2016-12-31 was $0.00.
  • SCYNEXIS, Inc. proceeds from issuance of secured debt for the quarter ending 2015-12-31 was $0.00.
  • SCYNEXIS, Inc. proceeds from issuance of secured debt for fiscal 2016 was $15.00M.
  • SCYNEXIS, Inc. proceeds from issuance of secured debt for fiscal 2015 was $0.00.
  • SCYNEXIS, Inc. proceeds from issuance of secured debt for fiscal 2014 was $0.00.
Period endProceeds from Issuance of Secured Debt 3 monthProceeds from Issuance of Secured Debt 9 monthProceeds from Issuance of Secured Debt 12 month
2017-09-30$0.00
10-Q · filed 2017-11-07
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13
$15.00M
10-K · filed 2018-03-13
2016-09-30$15.00M
10-Q · filed 2017-11-07
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
$0.00
10-K · filed 2017-03-13
2015-09-30$0.00
10-Q · filed 2016-11-07
2014-12-31$0.00
10-K · filed 2017-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
PDS Biotechnology Corp (PDSB)United States$0.045B
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
VERU INC. (VERU)United States$0.043B-3.93
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
Kairos Pharma, LTD. (KAPA)United States$0.041B
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98